EUVIMEDAtrasti EUVIMED
CrossrefInformacijos kortelė

Gut microbiota and adolescent depression

Mariya A. Omelchenko, Leila R. Akhmadeeva, Vasilii O. Generalov, Marsel M. Tuygunov

Science and Innovations in Medicine · 2026-10-06 · 11 (4) · 282-286

DOI: 10.35693/sim706808 ↗
SantraukaBibliografiniai duomenys

Santrauka

This paper dwells on the connection between gut microbiota and depression in adolescents, along with a case report of a 15-year-old patient with a mild depressive episode who was treated primarily by targeting the gut microbiota. This therapeutic approach is pathogenetically justified by the specific nature of adolescent depression, in which the elevated reactivity of the limbic system plays a significant role. Given the limbic system’s high sensitivity to signals from the hypothalamic-pituitary-adrenal (HPA) axis, reducing HPA axis hyperactivity is a key component of therapy. The most accessible target for mitigating the negative impact of stress on HPA axis function, within the “microbiota-gut-brain” axis, is the initial link in the chain: the microbiota itself. Consequently, the use of probiotic agents, which offer both a favorable safety profile and proven efficacy, holds promise for the treatment and prevention of adolescent depression.

Jūsų darbui tinkamos žinios.

Nuo nemokamos pradžios ir asmeninės literatūros paieškos iki viso Research Suite.

Peržiūrėti tarifus →

Ar įtraukti visi leidėjų pilnieji tekstai?

Ne. Bibliografiniai įrašai, santraukos ir pilnieji tekstai yra skirtingas turinys. Ar pilnasis tekstas prieinamas, priklauso nuo šaltinio, Open Access ir jūsų turimų licencijų. EUVIMED planas nepakeičia papildomų leidėjų teisių.

Peržiūrėti tarifus →